University of Calgary

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease (2022) Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Atreya R, et al. Journal article The first virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic remission in Ulcerative Colitis (2022) Iacucci M, Cannatelli R, Parigi TL, Buda A, Labarile N, Nardone OM, Tontini GE, et al. Conference contribution A new simplified histology artificial intelligence system for accurate assessment of remission in Ulcerative Colitis (2022) Villanacci V, Parigi TL, Del Amor R, Esbri PM, Gui X, Bazarova A, Bhandari P, et al. Conference contribution A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis (2022) Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DE, Dörffel Y, Gordon SC, et al. Journal article Sr/Ca and Ba/Ca ratios support trophic partitioning within a Silurian conodont community from Gotland, Sweden (2022) Terrill DF, Jarochowska E, Henderson CM, Shirley B, Bremer O Journal article Endoscopic remission assessed with PICaSSO virtual electronic chromendoscopy accurately predicts clinical outcomes in ulcerative colitis (2022) Nardone OM, Bazarova A, Bhandari P, Cannatelli R, Daperno M, Ferraz J, Goetz M, et al. Journal article One EEG, one read – A manifesto towards reducing interrater variability among experts (2022) Nascimento FA, Jing J, Beniczky S, Benbadis SR, Gavvala JR, Yacubian EM, Wiebe S, et al. Journal article Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients (2021) Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, et al. Journal article De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability (2021) Schalk A, Cousin MA, Challman TD, Wain KE, Powis Z, Minks K, Trimouille A, et al. Journal article MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2021) Kang EY, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, et al. Journal article